Company / Current Assets per Share
Amylyx Pharmaceuticals, Inc. Current Assets per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.95
FY2025
5-year range
$2.76 / $54.43
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#162 of 210
Health Care
What the data says
Amylyx Pharmaceuticals, Inc.'s current assets per share of $2.95 is lower than 77% of companies in the Health Care sector (FY2025). Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $2.95.
Based on SEC 10-K filings.
2.95 in FY2025 with a 3-year CAGR of -62.2%.
Declined from $6.86 to $2.95 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -62.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 210This company $2.95 Sector average $170.65
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 6.7% year-over-year.
- Ranks #162 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.95 | +6.7% |
| FY2024 | $2.76 | -59.8% |
| FY2023 | $6.86 | -87.4% |
| FY2022 | $54.43 | +241.6% |
| FY2021 | $15.93 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026